Skip to content
10-Q

Quarterly Report

LISATA THERAPEUTICS, INC. LSTA

0000320017-25-000070

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 6, 2025 8.82M sh
Shares Diluted Q3 2025 · Sep 30, 2025 8.74M sh
Shares Diluted Q3 2025 · Sep 30, 2025 8.65M sh
Shares Diluted Q3 2025 · Sep 30, 2024 8.32M sh
Shares Diluted Q3 2025 · Sep 30, 2024 8.31M sh
Capex Q3 2025 · Sep 30, 2025 $28K
Capex Q3 2025 · Sep 30, 2024 $0
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$12.7M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$14.83M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $19M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $16.21M
Stockholders Equity Q3 2025 · Sep 30, 2025 $17.37M
Stockholders Equity Q3 2025 · Dec 31, 2024 $29.57M
Current Liabilities Q3 2025 · Sep 30, 2025 $4.57M
Current Liabilities Q3 2025 · Dec 31, 2024 $5.61M
Total Liabilities Q3 2025 · Sep 30, 2025 $4.64M
Total Liabilities Q3 2025 · Dec 31, 2024 $5.69M
Current Assets Q3 2025 · Sep 30, 2025 $21.58M
Current Assets Q3 2025 · Dec 31, 2024 $34.58M
Total Assets Q3 2025 · Sep 30, 2025 $21.76M
Total Assets Q3 2025 · Dec 31, 2024 $35M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.49
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.58
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.59
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.85
Eps Basic Q3 2025 · Sep 30, 2025 −$0.49
Eps Basic Q3 2025 · Sep 30, 2025 −$1.58
Eps Basic Q3 2025 · Sep 30, 2024 −$0.59
Eps Basic Q3 2025 · Sep 30, 2024 −$1.85
Sga Expense Q3 2025 · Sep 30, 2025 $2.46M
Sga Expense Q3 2025 · Sep 30, 2025 $8.39M
Sga Expense Q3 2025 · Sep 30, 2024 $2.79M
Sga Expense Q3 2025 · Sep 30, 2024 $9.08M
Net Income Q3 2025 · Sep 30, 2025 −$4.25M
Net Income Q3 2025 · Sep 30, 2025 −$13.63M
Net Income Q3 2025 · Sep 30, 2024 −$4.93M
Net Income Q3 2025 · Sep 30, 2024 −$15.38M
Operating Income Q3 2025 · Sep 30, 2025 −$4.41M
Operating Income Q3 2025 · Sep 30, 2025 −$15.13M
Operating Income Q3 2025 · Sep 30, 2024 −$5.34M
Operating Income Q3 2025 · Sep 30, 2024 −$17.46M
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $70K
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $0